Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K35/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.102021207747Produktionsanlage und Verfahren zur Herstellung eines Produkts
DE 26.01.2023
Int.Class A61K 35/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Appl.No 102021207747 Applicant KyooBe Tech GmbH Inventor Bott Mario

Die vorliegende Anmeldung betrifft eine Produktionsanlage (10), insbesondere zur Herstellung von biologisch-pharmazeutischen Produkten (20), und/oder ein Verfahren zur Herstellung eines Produkts (20), insbesondere eines biologisch-pharmazeutischen Produkts (20). embedded image

2.WO/2023/001982MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION
WO 26.01.2023
Int.Class G01N 33/50
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Appl.No PCT/EP2022/070541 Applicant UNIVERSITÄT BASEL Inventor FLOHR, Alexander
The present invention relates to ligands specifically presented by MR1 molecules to MR1-specific T cells. These ligands are derivatives or analogues of nucleic acid forming bases, particularly ribonucleoside and deoxyribonucleoside adducts occurring in eukaryotic cells under certain conditions. The invention further relates to pharmaceutical preparations and methods for use of such ligands in treatment and research. The invention further relates to pharmaceutical preparations provided with the aim of modulating presentation of MR1 ligands in clinical situations where such modulated presentation of MR1 ligands is of clinical benefit.
3.102021207746Produktionsanlage und Verfahren zur Herstellung eines Produkts
DE 26.01.2023
Int.Class B65G 1/04
BPERFORMING OPERATIONS; TRANSPORTING
65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
GTRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
1Storing articles, individually or in orderly arrangement, in warehouses or magazines
02Storage devices
04mechanical
Appl.No 102021207746 Applicant KyooBe Tech GmbH Inventor Bott Mario

Die vorliegende Anmeldung betrifft eine Produktionsanlage (10), insbesondere zur Herstellung von biologisch-pharmazeutischen Produkten (20), und/oder ein Verfahren zur Herstellung eines Produkts (20), insbesondere eines biologisch-pharmazeutischen Produkts (20). embedded image

4.WO/2023/001368PREVENTION AND/OR TREATMENT OF REWARD DYSREGULATION DISORDERS
WO 26.01.2023
Int.Class A61K 35/74
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
Appl.No PCT/EP2021/070303 Applicant UNIVERSITÉ CATHOLIQUE DE LOUVAIN Inventor EVERARD, Amandine
The present invention relates to a composition comprising one or more bacteria from the genus Parabacteroides and/or an extract thereof, for use in preventing and/or treating reward dysregulation disorders.
5.WO/2023/003138POWDER, PILL, OR LIQUID FORM HERBAL MEDICINE COMPOSITION FOR FRACTURE RESTORATION AND BONE REGENERATION SPEED IMPROVEMENT, AND POWDER, PILL, OR LIQUID FORM HERBAL MEDICINE PREPARATION USING SAME
WO 26.01.2023
Int.Class A61K 36/232
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
232Angelica
Appl.No PCT/KR2022/006073 Applicant CHOI, Young Jin Inventor CHOI, Young Jin
The present invention relates to a powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement, and a powder, pill, or liquid form herbal medicine preparation using same and, more specifically, to a powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement and a powder, pill, or liquid form herbal medicine preparation using the same, the composition having medicinal materials capable of promoting fracture restoration and bone regeneration and medicinal materials capable of increasing digestion and absorption that are mixed to enable the promotion of fracture restoration and bone regeneration effects. A powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement, of the present invention, comprises 20 parts by weight of Angelica gigas, 16 parts by weight of Dendrobium moniliforme, 12 parts by weight of Phlomis umbrosa, 10 parts by weight of Cervi cornu, 8 parts by weight of Cnidium officinale, 8 parts by weight of Astragalus membranaceus, 4 parts by weight of Achyranthes japonica, and 4 parts by weight of Massa Medicata Fermentata.
6.WO/2023/001833METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS
WO 26.01.2023
Int.Class C12N 5/0783
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
071Vertebrate cells or tissues, e.g. human cells or tissues
078Cells from blood or from the immune system
0783T cells; NK cells; Progenitors of T or NK cells
Appl.No PCT/EP2022/070224 Applicant REPAIRON IMMUNO GMBH Inventor BAKAR, Mine
The present invention relates to a method of producing a population of immune cells, the population of immune cells obtainable or obtained by the method of the invention, non- immunogenic T cell obtainable or obtained by the method of the invention, pharmaceutical composition comprising the immune cells or non-immunogenic T cells of the invention, as well as to the population of immune cells, the non-immunogenic T cell or the pharmaceutical composition for use in a method of treatment, or the use in cell therapy.
7.WO/2023/003357COMPOSITION COMPRISING SUPEROXIDE DISMUTASE AND/OR BACILLUS STRAIN SPORES, AND USE THEREOF FOR IMPROVING ORAL HEALTH
WO 26.01.2023
Int.Class A61K 8/66
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
64Proteins; Peptides; Derivatives or degradation products thereof
66Enzymes
Appl.No PCT/KR2022/010623 Applicant GENOFOCUS CO., LTD. Inventor PAN, Jae Gu
The present invention relates to an oral composition comprising the superoxide dismutase (SOD) enzyme and/or Bacillus spp. strain spores, and a use thereof for improving oral health or managing oral hygiene. The composition may be useful for preventing or treating oral diseases such as oral pain, halitosis, tartar, plaque, gingivitis, and periodontitis, without causing adverse effects in the oral cavity.
8.WO/2023/004287COMBINATION OF CHECKPOINT INHIBITORS AND AN ONCOLYTIC VIRUS FOR TREATING CANCER
WO 26.01.2023
Int.Class A61K 35/768
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
768Oncolytic viruses not provided for in groups A61K35/761-A61K35/76697
Appl.No PCT/US2022/073845 Applicant REGENERON PHARMACEUTICALS, INC. Inventor DADI-MEHMETAJ, Saida
This disclosure relates to novel triple combination therapies of an oncolytic virus, a PD-1 pathway inhibitor, and a CTLA4 inhibitor for treating or inhibiting the growth of a tumor in a patient with cancer.
9.WO/2023/004377PROMOTING IMMUNE SURVEILLANCE AGAINST CANCER CELLS
WO 26.01.2023
Int.Class A61K 35/13
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
13Tumour cells, irrespective of tissue of origin
Appl.No PCT/US2022/073986 Applicant MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH Inventor VAN DEURSEN, Jan M.A.
This document provides methods and materials involved in promoting immune surveillance against cancer cells. For example, methods and materials administering one or more chemokine (C-X-C motif) ligand 14 (CXCL14) polypeptides (and/or nucleic acids designed to encode a CXCL14 polypeptide) to cancer cells within a mammal (e.g., a human) having cancer to promote immune surveillance against the cancer cells are provided.
10.WO/2023/001783METHOD OF PREPARING A PHOSPHOLIPID-ENRICHED, WHEY-DERIVED COMPOSITION HAVING A LOW CONTENT OF MICROORGANISMS, THE COMPOSITION AS SUCH, AND NUTRITIONAL USE OF THE COMPOSITION
WO 26.01.2023
Int.Class A23J 1/20
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
1Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
20from milk, e.g. casein; from whey
Appl.No PCT/EP2022/070107 Applicant ARLA FOODS AMBA Inventor BERTELSEN, Hans
The invention relates to a method of preparing a whey-derived composition enriched with respect to whey phospholipids by membrane filtration, and preferably also enriched with respect to other membrane components from whey. The membrane filtration is furthermore followed by a special microfiltration-based germ filtration which the inventors have found to be efficient for reducing the microbial content of the whey-derived composition while keeping nutritionally important components in the whey-derived composition. The invention furthermore relates to the whey-derived composition as such, use of the whey-derived composition as in ingredient in nutritional products, and to nutritional products comprising the whey-derived composition.